Adipose tissue fatty acids in breast cancer patients versus healthy control women from crete

Annals of Nutrition and Metabolism

Volumn 54, Issue 4, 2009, Pages 275-282

  Mamalakis, G ^a   Hatzis, C ^a   De Bree, E ^b   Sanidas, E ^b   Tsiftsis, D D ^b   Askoxylakis, J ^b   Daskalakis, M ^b   Tsibinos, G ^a   Kafatos, A ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Adipose tissue; Biomarkers; Breast cancer; Case control study; Fatty acids; Human; Saturated fat

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FAS ANTIGEN; FATTY ACID; MYRISTIC ACID; OLEIC ACID;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; FATTY ACID SYNTHESIS; FEMALE; GAS CHROMATOGRAPHY; GREECE; HISTOLOGY; HUMAN; HUMAN TISSUE; LIPID COMPOSITION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; ONCOGENE NEU; PRIORITY JOURNAL; TUMOR PROMOTION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BREAST NEOPLASMS; BUTTOCKS; CASE-CONTROL STUDIES; FATTY ACIDS; FEMALE; GREECE; HUMANS; MIDDLE AGED; MYRISTIC ACID; NEOPLASM STAGING; OLEIC ACID; RISK FACTORS; STATISTICS AS TOPIC; SUBCUTANEOUS FAT; TUMOR BURDEN; YOUNG ADULT;

EID: 67651208230     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000229508     Document Type: Article

References (60)

1. Boyd NF, Martin LJ, Noffel M, Lockwood GA, Trichler DL: A meta-analysis of studies of dietary fat and breast cancer risk. Br J Cancer 1993; 68: 627-636.
2. Thiébaut AC, Kipnis V, Chang SC, Subar AF, Thompson FE, Rosenberg PS, Hollenbeck AR, Leitzmann M, Schatzkin A: Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP Diet and Health Study cohort. J Natl Cancer Inst 2007; 99: 451-462. (Pubitemid 47073568)
3. Bingham SA, Luben R, Welch A, Wareham N, Khaw KT, Day N: Are imprecise methods obscuring a relation between fat and breast cancer? Lancet 2003; 362: 212-214.
4. Wirfält E, Mattisson I, Gullberg B, Johansson U, Olsson H, Berglund G: Postmenopausal breast cancer is associated with high intakes of omega6 fatty acids (Sweden). Cancer Causes Control 2002; 13: 883-893.
5. Löf M, Sandin S, Lagiou P, Hilakivi-Clarke L, Trichopoulos D, Adami HO, Weiderpass E: Dietary fat and breast cancer risk in the Swedish women's lifestyle and health cohort. Br J Cancer 2007; 97: 1570-1576.
6. Gago-Dominguez M, Yuan JM, Sun CL, Lee HP, Yu MC: Opposing effects of dietary n-3 and n-6 fatty acids on mammary carcinogenesis: the Singapore Chinese Health Study. Br J Cancer 2003; 89: 1686-1692.
7. Voorrips LE, Brants HA, Kardinaal AF, Hiddink GJ, van den Brandt PA, Goldbohm RA: Intake of conjugated linoleic acid, fat, and other fatty acids in relation to postmenopausal breast cancer: the Netherlands Cohort Study on Diet and Cancer. Am J Clin Nutr 2002; 76: 873-882.
8. Borgquist S, Wirfält E, Jirström K, Anagnostaki L, Gullberg B, Berglund G, Manjer J, Landberg G: Diet and body constitution in relation to subgroups of breast cancer defined by tumour grade, proliferation and key cell cycle regulators. Breast Cancer Res 2007; 9:R11.
9. Lee MM, Lin SS: Dietary fat and breast cancer. Annu Rev Nutr 2000; 20: 221-248.
10. Cantwell MM: Assessment of individual fatty acid intake. Proc Nutr Soc 2000; 59: 187-191.
11. Bingham SA: Limitations of the various methods for collecting dietary intake data. Ann Nutr Metab 1991; 35: 117-127.
12. Thiébaut AC, Chajès V, Clavel-Chapelon F, Gerber M: Unsaturated fatty acids intake and breast cancer risk: epidemiological data review. Bull Cancer 2005; 92: 658-669.
13. Saadatian-Elahi M, Norat T, Goudable J, Riboli E: Biomarkers of dietary fatty acid intake and the risk of breast cancer: a metaanalysis. Int J Cancer 2004; 111: 584-591.
14. Hirsch J, Farquhar JW, Ahrens EH, Peterson ML, Stoffel W: Studies of adipose tissue in man. A microtechnic for sampling and analysis. Am J Clin Nutr 1960; 8: 499-511.
15. Dayton S, Hashimoto S, Dixon W, Pearce ML: Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. J Lipid Res 1966; 7: 103-111.
16. Katan MB, Deslypere JP, van Birgelen AP, Penders M, Zegwaard M: Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res 1997; 38: 2012-2022.
17. Bloom HJ, Richardson WW: Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 1957; 11: 359-377.
18. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 403-410.
19. Singletary SE, Allred C, Ashley P, et al.: Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002; 20: 3628-3636.
20. Beynen AC, Katan MB: Why do polyunsaturated fatty acids lower serum cholesterol? Am J Clin Nutr 1985; 42: 560-563.
21. Metcalfe LD, Schmitz AA, Pekka JR: Rapid preparation of fatty acid esters from lipids for gas chromatographic analysis. Ann Chem 1966; 18: 514-515.
22. Löf M, Sandin S, Lagiou P, Hilakivi-Clarke L, Trichopoulos D, Adami HO, Weiderpass E: Dietary fat and breast cancer risk in the Swedish women's lifestyle and health cohort. Br J Cancer 2007; 97: 1570-1576.
23. García-Segovia P, Sánchez-Villegas A, Doreste J, Santana F, Serra-Majem L: Olive oil consumption and risk of breast cancer in the Canary Islands: a population-based casecontrol study. Public Health Nutr 2006; 9: 163-167.
24. World Cancer Research Fund/American Institute for Cancer Research: Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington DC 2007, p 295.
25. Witte JS, Ursin G, Siemiatycki J, Thompson WD, Paganini-Hill A, Haile RW: Diet and premenopausal bilateral breast cancer: a case-control study. Breast Cancer Res Treat 1997; 42: 243-251.
26. Zaridze DG, Chevchenko VE, Levtshuk AA, Lifanova YE, Maximovitch DM: Fatty acid composition of phospholipids in erythrocyte membranes and risk of breast cancer. Int J Cancer 1990; 45: 807-810.
27. Menendez JA, Vellon L, Colomer R, Lupu R: Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB- 2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin) in breast cancer cells with Her- 2/neu oncogene amplification. Ann Oncol 2005; 16: 359-371.
28. Menendez JA, Papadimitropoulou A, Vellon L, Lupu R: A genomic explanation connecting 'Mediterranean diet', olive oil and cancer: oleic acid, the main monounsaturated fatty acid of olive oil, induces formation of inhibitory 'PEA3 transcription factor-PEA3 DNA binding site' complexes at the Her-2/ neu (erbB-2) oncogene promoter in breast, ovarian and stomach cancer cells. Eur J Cancer 2006; 42: 2425-2432.
29. Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R: Novel signaling molecules implicated in tumor-associated fatty acid synthasedependent breast cancer cell proliferation and survival: role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF- B. Int J Oncol 2004; 24: 591-608.
30. Menendez JA, Vazquez-Martin A, Garcia- Villalba R, Carrasco-Pancorbo A, Oliveras-Ferraros C, Fernandez-Gutierrez A, Segura- Carretero A: tabAnti-HER2 (erbB-2) oncogene effects of phenolic compounds directly isolated from commercial Extra- Virgin Olive Oil (EVOO). BMC Cancer 2008; 8: 377.
31. Menendez JA, Vazquez-Martin A, Colomer R, Brunet J, Carrasco-Pancorbo A, Garcia- Villalba R, Fernandez-Gutierrez A, Segura- Carretero A: Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin) in HER2-overexpressing breast cancer cells. BMC Cancer 2007; 7: 80.
32. Hardy S, Langelier Y, Prentki M: Oleate activates phosphatidylinositol 3-kinase and promotes proliferation and reduces apoptosis of MDA-MB-231 breast cancer cells, whereas palmitate has opposite effects. Cancer Res 2000; 60: 6353-6358.
33. Hardy S, El-Assaad W, Przybytkowski E, Joly E, Prentki M, Langelier Y: Saturated fatty acid-induced apoptosis in MDA-MB-231 breast cancer cells. A role for cardiolipin. J Biol Chem 2003; 278: 31861-31870.
34. Hardy S, St-Onge GG, Joly E, Langelier Y, Prentki M: Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40. J Biol Chem 2005; 280: 13285-13291.
35. Przybytkowski E, Joly E, Nolan CJ, Hardy S, Francoeur AM, Langelier Y, Prentki M: Upregulation of cellular triacylglycerol - free fatty acid cycling by oleate is associated with long-term serum-free survival of human breast cancer cells. Biochem Cell Biol 2007; 85: 301-310.
36. Saadatian-Elahi M, Toniolo P, Ferrari P, Goudable J, Akhmedkhanov A, Zeleniuch-Jacquotte A, Riboli E: Serum fatty acids and risk of breast cancer in a nested case-control study of the New York University Women's Health Study. Cancer Epidemiol Biomarkers Prev 2002; 11: 1353-1360.
37. Pala V, Krogh V, Muti P, Chajès V, Riboli E, Micheli A, Saadatian M, Sieri S, Berrino F: Erythrocyte membrane fatty acids and subsequent breast cancer: a prospective Italian study. J Natl Cancer Inst 2001; 93: 1088-1095.
38. Aro A, Männistö S, Salminen I, Ovaskainen ML, Kataja V, Uusitupa M: Inverse association between dietary and serum conjugated linoleic acid and risk of breast cancer in postmenopausal women. Nutr Cancer 2000; 38: 151-157.
39. Ways DK, Kukoly CA, deVente J, Hooker JL, Bryant WO, Posekany KJ, Fletcher DJ, Cook PP, Parker PJ: MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. J Clin Invest 1995; 95: 1906-1915.
40. Morse-Gaudio M, Connolly JM, Rose DP: Protein kinase C and its isoforms in human breast cancer cells: relationship to the invasive phenotype. Int J Oncol 1998; 12: 1349-1354.
41. Sledge GW Jr, Gökmen-Polar Y: Protein kinase C- as a therapeutic target in breast cancer. Semin Oncol 2006; 33(suppl 9):15-18.
42. Kasahara K, Kikkawa U: Distinct effects of saturated fatty acids on protein kinase C subspecies. J Biochem 1995; 117: 648-653.
43. Kusakabe T, Maeda M, Hoshi N, Sugino T, Watanabe K, Fukuda T, Suzuki T: Fatty acid synthase is expressed mainly in adult hormone- sensitive cells or cells with high lipid metabolism and in proliferating fetal cells. J Histochem Cytochem 2000; 48: 613-622.
44. Agostini M, Silva SD, Zecchin KG, Coletta RD, Jorge J, Loda M, Graner E: Fatty acid synthase is required for the proliferation of human oral squamous carcinoma cells. Oral Oncol 2004; 40: 728-735.
45. Kuhajda FP, Jenner K, Wood FD, Hennigar RA, Jacobs LB, Dick JD, Pasternack GR: Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc Natl Acad Sci USA 1994; 91: 6379-6383.
46. Furuta E, Pai SK, Zhan R, Bandyopadhyay S, Watabe M, Mo YY, Hirota S, Hosobe S, Tsukada T, Miura K, Kamada S, Saito K, Iiizumi M, Liu W, Ericsson J, Watabe K: Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Res 2008; 68: 1003-1011.
47. Menendez JA, Lupu R: Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 2007; 7: 763-777.
48. Gao Y, Lin LP, Zhu CH, Chen Y, Hou YT, Ding J: Growth arrest induced by C75, a fatty acid synthase inhibitor, was partially modulated by p38 MAPK but not by p53 in human hepatocellular carcinoma. Cancer Biol Ther 2006; 5: 978-985.
49. Li JN, Gorospe M, Chrest FJ, Kumaravel TS, Evans MK, Han WF, Pizer ES: Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53. Cancer Res 2001; 61: 1493-1499.
50. Zhou W, Simpson PJ, McFadden JM, Townsend CA, Medghalchi SM, Vadlamudi A, Pinn ML, Ronnett GV, Kuhajda FP: Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells. Cancer Res 2003; 63: 7330-7337.
51. Bandyopadhyay S, Zhan R, Wang Y, Pai SK, Hirota S, Hosobe S, Takano Y, Saito K, Furuta E, Iiizumi M, Mohinta S, Watabe M, Chalfant C, Watabe K: Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells. Cancer Res 2006; 66: 5934-5940.
52. Menendez JA, Vellon L, Mehmi I, Oza BP, Ropero S, Colomer R, Lupu R: Inhibition of fatty acid synthase (FAS) suppresses HER2/ neu (erbB-2) oncogene overexpression in cancer cells. Proc Natl Acad Sci USA 2004; 101: 10715-10720.
53. Menendez JA, Lupu R, Colomer R: Targeting fatty acid synthase: potential for therapeutic intervention in her-2/neu-overexpressing breast cancer. Drug News Perspect 2005; 18: 375-385.
54. Jain M, Miller AB, To T: Premorbid diet and the prognosis of women with breast cancer. J Natl Cancer Inst 1994; 86: 1390-1397. (Pubitemid 24283358)
55. Petrek JA, Hudgins LC, Ho M, Bajorunas DR, Hirsch J: Fatty acid composition of adipose tissue, an indication of dietary fatty acids, and breast cancer prognosis. J Clin Oncol 1997; 15: 1377-1384.
56. Bates CJ, Thurnham DI, Bingham SA, Margetts BM, Nelson M. Biochemical markers of nutrient intake; in Margets BM, Nelson M (eds): Design Concepts in Nutritional Epidemiology Oxford, Oxford University Press, 1997, pp 170-240.
57. Beynen AC, Hermus RJ, Hautvast JG: A mathematical relationship between the fatty acid composition of the diet and that of the adipose tissue in man. Am J Clin Nutr 1980; 33: 81-85.
58. Bagga D, Capone S, Wang HJ, Heber D, Lill M, Chap L, Glaspy JA: Dietary modulation of omega-3/omega-6 polyunsaturated fatty acid ratios in patients with breast cancer. J Natl Cancer Inst 1997; 89: 1123-1131.
59. Kabagambe EK, Baylin A, Allan DA, Siles X, Spiegelman D, Campos H: Application of the method of triads to evaluate the performance of food frequency questionnaires and biomarkers as indicators of long-term dietary intake. Am J Epidemiol 2001; 154: 1126-1135.
60. Victor TA, Bergman A, Knop RH: Detecting fatty acids of dietary origin in normal and cancerous human breast tissue by 13C nuclear magnetic resonance spectroscopy. Br J Cancer 1993; 68: 336-341.